Rosiptor is primarily used in the field of medical research and treatment, particularly in studies related to cardiovascular health. It acts as a potent activator of soluble guanylate cyclase (sGC), an enzyme that plays a crucial role in regulating blood pressure and vascular tone. By enhancing sGC activity, it helps in the relaxation of blood vessels, improving blood flow and reducing hypertension. This makes it a valuable compound in the development of therapies for conditions such as pulmonary arterial hypertension and chronic heart failure. Additionally, its mechanism of action is being explored for potential benefits in treating other vascular disorders and improving endothelial function. Researchers also investigate its use in combination with other drugs to enhance therapeutic outcomes in cardiovascular diseases.